HOME >> BIOLOGY >> NEWS
Amid growing public concerns, bioscience firms begin formalizing ethical decision-making practices

Pharmaceutical, biotechnology and bio-agricultural companies, grappling with an array of complex ethical issues, are gradually formalizing systematic approaches to ethical decision-making, according to a two-year study by leading international ethics and bioscience researchers.

Bioscience companies operations pose many ethical dilemmas. They produce and sell genetically modified foods, conduct gene therapy experiments and embryonic stem cell research to produce new therapies, use animals to test new pharmaceuticals, manipulate life'TMs building blocks, create transgenic animals to produce drugs, commercialize genetic and biological materials, compile and use personal genetic information, and set drug prices for domestic and developing country markets.

Companies of all sizes and in all sectors, faced with growing questions and concerns, are recognizing and acting on public pressure to demonstrate business methods that are not just legal but ethical too, according to research conducted jointly by the Joint Centre for Bioethics (JCB) at the University of Toronto, the Keck Graduate Institute of Applied Life Sciences (Claremont CA), Stanford University (Palo Alto, CA), and l'TMUniversite de Montreal.

More than 100 in-depth interviews with managers and top executives at 13 diverse bioscience firms, large and small, all with reputations for developing new approaches, were conducted to capture and summarize the way the industry innovators today address ethical challenges. The research represents some of the first empirical evidence of how bioscience companies are dealing with ethical issues now, establishing a constructive starting point on which to build.

The research results are newly published in the book Bioindustry Ethics (Elsevier Academic Press), with a summary (and accompanying editorial) published today by PLOS Medicine, the paper entitled "Lessons on Ethical Decision Making fro
'"/>

Contact: Terry Collins
terrycollins@rogers.com
416-538-8712
University of Toronto Joint Center for Bioethics
3-Apr-2006


Page: 1 2 3 4 5

Related biology news :

1. Citrus greening continues to spread in citrus growing areas
2. Threats to wild tigers growing
3. FSU engineering professor growing bone in a lab
4. Use of wind energy in US growing, but planning and guidelines are lacking
5. MIT creates 3-D scaffold for growing stem cells
6. A new approach to growing heart muscle
7. A giant among minnows: Giant danio can keep growing
8. After North Korea test, what can be done to reduce the growing nuclear threat?
9. Genomatix appoints distributor for the growing Chinese market
10. Minimal cocktail for growing human embryonic stem cells established
11. New journal article urges use of animal serum-free media for growing live cells

Post Your Comments:
(Date:6/8/2015)... SAN DIEGO , June 8, 2015  Trovagene, Inc. ... announced today that clinical data featuring its Precision Cancer Monitoring ... Cancer Markers and Liquid Biopsies conference in San ... the AACR Precision Medicine Series: Integrating Clinical Genomics and ... on June 13-16. "We continue ...
(Date:6/5/2015)... GERMANTOWN, Md. , June 5, 2015  Intrexon ... synthetic biology, today announced that it has determined the ... of all of its 17,830,305 shares of ZIOPHARM Oncology, ... or about June 12, 2015, the distribution date, as ... stock, and on warrants to purchase shares of Intrexon ...
(Date:6/1/2015)... -- According to a new market research ... (Touch-based & Touchless), Application (Consumer Electronics, Automotive, & Others), ... Global Forecast to 2020", published by MarketsandMarkets, the Gesture ... $23.55 Billion by 2020, at a CAGR of 28.23% ... market data T ables and   86   ...
Breaking Biology News(10 mins):Clinical Data Featuring Trovagene's Urine-Based Liquid Biopsy Platform to be Presented at Two Upcoming Medical Conferences 2Clinical Data Featuring Trovagene's Urine-Based Liquid Biopsy Platform to be Presented at Two Upcoming Medical Conferences 3Clinical Data Featuring Trovagene's Urine-Based Liquid Biopsy Platform to be Presented at Two Upcoming Medical Conferences 4Intrexon Announces Distribution Ratio for Distribution of ZIOPHARM Shares 2Intrexon Announces Distribution Ratio for Distribution of ZIOPHARM Shares 3Intrexon Announces Distribution Ratio for Distribution of ZIOPHARM Shares 4Gesture Recognition & Touchless Sensing Market Worth $23.55 Billion by 2020 2Gesture Recognition & Touchless Sensing Market Worth $23.55 Billion by 2020 3Gesture Recognition & Touchless Sensing Market Worth $23.55 Billion by 2020 4
(Date:6/26/2015)... MUMBAI, India , June 26, 2015 ... a leading global IT services, consulting and business solutions ... Leader in Worldwide Life Sciences R&D Risk-Based Monitoring by ... MarketScape: Worldwide Life Science R&D Risk-Based Monitoring 2015 Vendor ... The report evaluated eight leading IT services vendors with ...
(Date:6/26/2015)... ... June 26, 2015 , ... ReliantHeart, Inc. , an innovative supplier of ... implant of the HeartAssist5® LVAD (HA5) to the 68th consecutive implant, there has been ... originates in an LVAD is referred to as de novo thrombus. De novo thrombus ...
(Date:6/25/2015)... ... 2015 , ... Students entering the new Hemenway Hall addition ... exclusively using filtered fume hoods that feature Erlab’s GreenFumeHood Filtration Technology . ... needed for their Organic, Inorganic, Analytical, and Physical Chemistry teaching laboratories. Each filtered ...
(Date:6/25/2015)... , June 25, 2015 /PRNewswire/ - Portage Biotech ... , OTC Markets : PTGEF,), is pleased to announce ... US$5,155,080 through issuance of approximately 36.8 million common shares ... two tranches, first tranche closed on June 15, 2015 ... and second and final tranche closed on June 24, ...
Breaking Biology Technology:TCS Recognized as a Leader in Life Sciences R&D Risk-Based Monitoring by IDC MarketScape 2TCS Recognized as a Leader in Life Sciences R&D Risk-Based Monitoring by IDC MarketScape 3TCS Recognized as a Leader in Life Sciences R&D Risk-Based Monitoring by IDC MarketScape 4HeartAssist5® Remote Monitoring has alerted no patterns of de novo thrombus in 68 consecutive implants 2HeartAssist5® Remote Monitoring has alerted no patterns of de novo thrombus in 68 consecutive implants 3This Summer Erlab Completes the Largest Installation of Filtered Fume Hoods in the World 2Portage Completes Non-brokered Private Placement in Two Tranches for a Total Proceeds of US$ 5,155,080 2Portage Completes Non-brokered Private Placement in Two Tranches for a Total Proceeds of US$ 5,155,080 3
Cached News: